biguanides has been researched along with Local Neoplasm Recurrence in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olaparib is a PARP inhibitor approved for maintenance therapy following platinum-based chemotherapy." | 1.56 | Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail. ( Amin, O; Baloch, T; Bithras, J; Kessous, R; Kogan, L; Laskov, I; López-Ozuna, VM; Wang, Q; Yasmeen, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Q | 1 |
| López-Ozuna, VM | 1 |
| Baloch, T | 1 |
| Bithras, J | 1 |
| Amin, O | 1 |
| Kessous, R | 1 |
| Kogan, L | 1 |
| Laskov, I | 1 |
| Yasmeen, A | 1 |
1 other study available for biguanides and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biguanides; Carcinogenesis; Cell Line, Tumor; Cell M | 2020 |